Can an app save lives from overdose? philly trial aims to find out
NCT ID NCT06466005
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This study tests whether a smartphone app called UnityPhilly can help bystanders quickly respond to opioid overdoses with naloxone. About 450 adults who live or work in three Philadelphia neighborhoods will use the app and receive training. Researchers will track how many overdoses are signaled through the app and how many are successfully reversed over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- UnityPhilly app (smartphone app for coordinating overdose response)
- What this could lead to
- If successful, this app could help save lives by getting naloxone to overdose victims faster, reducing deaths in high-risk areas.
- What could go wrong
- This is a single-city study with 450 participants, so results may not apply elsewhere. App usage and response rates may be lower than expected, limiting real-world impact.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID OVERDOSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Drexel University
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
- ER opioid overdose study pulled before it began
- Can a computer predict overdose outbreaks? rhode island trial tests new tool
- New naloxone spray tested for faster overdose help
- New nalmefene study could speed up opioid overdose rescue
- ER study sheds light on hidden xylazine in opioid overdoses